Skip to main content
Fig. 1 | BMC Family Practice

Fig. 1

From: Rationale and design of a pragmatic clinical trial to assess the impact of self-monitoring blood pressure at home and self-titration of antihypertensive medication in poorly controlled hypertension: the ADAMPA study protocol

Fig. 1

SPIRIT flow diagram: Schedule of enrolment, interventions, and assessments in the ADAMPA study. BP Blood pressure, SMBP Self-monitoring blood pressure, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, PDC Proportion of Days Covered. * Defined as period of continuous use of the corresponding drug from the beginning of the follow-up until its discontinuation. ** Defined as the number of patients whose pharmacological treatment had not been modified, divided by the number of patients not reaching the target values (SBP and/or DBP measurements taken at 6 and 12 months of follow-up), according to the recommendations of the European Society of Hypertension and European Society of Cardiology

Back to article page